Title	Publication Date	Language	Citations
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators	1996/07/01	English	596
Drug-polymer conjugates	1992/06/01	English	326
PI3K/Akt/mTOR pathway as a target for cancer therapy	2005/09/01	English	325
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier	2007/01/01	English	291
Dendrimer-platinate	1999/09/01	English	278
Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines	1997/06/01	English	238
Histone deacetylase inhibitors in cancer treatment	2002/01/01	English	228
Targeting Stat3 in cancer therapy	2005/07/01	English	215
Liposomal encapsulated anti-cancer drugs	2005/08/01	English	206
Preclinical characteristics of gemcitabine	1995/12/01	English	191
Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I	1995/06/01	English	189
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent	2006/01/01	English	183
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers	1997/10/01	English	181
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines	1996/06/01	English	179
Mitomycin C	1990/10/01	English	173
Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays	1995/08/01	English	173
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy	1995/02/01	English	164
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel	2001/04/01	English	157
Gemcitabine—a safety review	1998/03/01	English	154
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly	2003/01/01	English	153
Enhancement of cytotoxicity by electropermeabilization	1998/04/01	English	151
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism	2005/03/01	English	150
Pilot phase l-ll study on 5-aza-2??-deoxycytidine (Decitabine) in patients with metastatic lung cancer	1997/04/01	English	146
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway	2003/02/01	English	143
The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells	2001/02/01	English	139
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay	1996/07/01	English	137
COX-2 inhibitors in cancer treatment and prevention, a recent development	2002/02/01	English	136
Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice	2001/11/01	English	128
Programmed cell death (apoptosis) and response to anti-cancer drugs	1994/02/01	English	125
Mechanism of action of rituximab	2002/11/01	English	122